Safety and effectiveness of remdesivir for the treatment of COVID-19 patients with end-stage renal disease: A retrospective cohort study

Safety and effectiveness of remdesivir for the treatment of COVID-19 patients with end-stage renal disease: A retrospective cohort study

Background: Remdesivir has been used to treat severe coronavirus 2019 (COVID-19); however, its safety and effectiveness in patients remain unclear. This study aimed to investigate the safety and effectiveness of remdesivir in patients with COVID-19 with end-stage renal disease (ESRD). Methods: This...

Full description

Bibliographic Details
Main Authors: Yan-Bo Huang, Chip-Jin Ng, Cheng-Hsun Chiu, Chung-Hsien Chaou, Shi-Ying Gao, Shou-Yen Chen
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
COVID-19
End-stage renal disease
Remdesivir
Side effects
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118223002335

Internet

http://www.sciencedirect.com/science/article/pii/S1684118223002335

Similar Items